Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

Visualizar Toda a Documentação

43659

Sigma-Aldrich

Glucosylsphingosine

≥98.0% (TLC)

Sinônimo(s):

(2S,3R,4E)-2-Amino-3-hydroxy-4-octadecen-1-yl β-D-glucopyranoside, 1-β-D-Glucosylsphingosine, Glucosyl-C18-sphingosine

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):
C24H47NO7
Número CAS:
52050-17-6
Peso molecular:
461.63
Beilstein:
4333674
Número MDL:
MFCD07374303
Código UNSPSC:
12352211
ID de substância PubChem:
329756364
NACRES:
NA.85

Nível de qualidade

100

Ensaio

≥98.0% (TLC)

Formulário

powder

tipo de lipídio

sphingolipids

temperatura de armazenamento

−20°C

cadeia de caracteres SMILES

O[C@@H]1[C@@H](O)[C@H](OC[C@H](N)[C@H](O)/C=C/CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O

InChI

1S/C24H47NO7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(27)18(25)17-31-24-23(30)22(29)21(28)20(16-26)32-24/h14-15,18-24,26-30H,2-13,16-17,25H2,1H3/b15-14+/t18-,19+,20?,21+,22+,23?,24+/m0/s1

chave InChI

HHJTWTPUPVQKNA-JLRUQHRASA-N

Ações bioquímicas/fisiológicas

Glucosylsphingosine is a cytotoxic compound. Accumulation of glucosylsphingosine in brain and other tissues occurs in patients with Gaucher disease, which is an inherited deficiency of lysosomal glucocerebrosidase, which converts glucosylsphingosine to glucose and sphingosine.

Código de classe de armazenamento

11 - Combustible Solids

Classe de risco de água (WGK)

WGK 3

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number
BCCG2390
BCCD1062
BCCB9443
BCBZ6356
BCBW4402

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Pesquise por COA

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Os clientes também visualizaram

Slide 1 of 9

1 of 9

Cerebrosides (Brain) Avanti Research™ - A Croda Brand

Avanti

131303P

Cerebrosides (Brain)

C17 Glucosyl(β) Ceramide (d18:1/17:0) Avanti Research™ - A Croda Brand 860569P, powder

Avanti

860569P

C17 Glucosyl(β) Ceramide (d18:1/17:0)

Lyso GB3 (synthetic) powder

Avanti

860952P

Lyso GB3 (synthetic)

Lyso GB3-d7 (synthetic) powder

Avanti

860682P

Lyso GB3-d7 (synthetic)

Brain PE Avanti Research™ - A Croda Brand 840022P, powder

Avanti

840022P

Brain PE

Galactocerebrosides from bovine brain ≥97% (TLC)

Sigma-Aldrich

C4905

Galactocerebrosides from bovine brain

Monosialoganglioside GM2 from bovine brain ≥95% (TLC)

Sigma-Aldrich

G8397

Monosialoganglioside GM2 from bovine brain

Sphingosine (d18:1) Avanti Research™ - A Croda Brand

Avanti

860490P

Sphingosine (d18:1)

Cholesterol β-D-glucoside ≥97% (TLC)

Sigma-Aldrich

28609

Cholesterol β-D-glucoside

E M Kaye et al.
Annals of neurology, 20(2), 223-230 (1986-08-01)
Glucocerebroside levels were measured in the brains of patients with neuronopathic forms (types 2 and 3) of Gaucher disease and compared to those obtained from control brain. Nine separate brain regions (frontal, temporal, occipital, and cerebellar cortices; thalamus; corpus striatum;
Wujuan Zhang et al.
The Analyst, 142(18), 3380-3387 (2017-08-16)
Gaucher disease (GD) is caused by mutations on the GBA1 gene leading to deficiency in acid β-glucosidase (GCase) and subsequent accumulation of its substrates, glucosylceramide (GlcC) and glucosylsphingosine (GlcS). GlcS in plasma has been proposed as a highly sensitive and
Chengfang Tang et al.
Clinical biochemistry, 87, 79-84 (2020-11-15)
Gaucher disease (GD) is caused by a deficiency of β-glucosidase (GCase), leading to accumulation of glucosylceramide (GlcC) and glucosylsphingosine (Lyso-Gb1). Lyso-Gb1 is a reliable biomarker for GD. This study aims to develop a simple, effective and accurate method for the
Ellen Sidransky
Molecular genetics and metabolism, 83(1-2), 6-15 (2004-10-07)
Gaucher disease, the recessively inherited deficiency of the enzyme glucocerebrosidase and the most common sphingolipidosis, has both non-neurological and neuronopathic forms and a continuum of diverse clinical manifestations. Studies of genotype-phenotype correlations reveal significant genotypic heterogeneity among clinically similar patients
E Beutler
Blood reviews, 2(1), 59-70 (1988-03-01)
Gaucher disease is a glycolipid storage disorder characterized by accumulation of glucocerebroside in the liver, spleen, and bones, and caused by a deficiency of glucocerebrosidase. Glucocerebrosidase cDNA has been cloned and sequenced, and much has been learned about the synthesis
Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica